The UMD-p53 database: New mutations and analysis tools

Human Mutation

Volumn 21, Issue 3, 2003, Pages 176-181

  Béroud, Christophe ^a   Soussi, Thierry ^b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Cancer; Database; Locus Specific Database; LSDB; Mutation analysis; p53; TP53; Tumor; UMD

Indexed keywords

PROTEIN P53;

AUTOMATION; CANCER; COMPUTER PROGRAM; DNA SPLICING; GENE MUTATION; GENETIC DATABASE; GENETIC POLYMORPHISM; INFORMATION PROCESSING; INTERNET; METHODOLOGY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; PUBLICATION; REVIEW; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

DATABASES, GENETIC; HUMANS; INTERNET; MUTATION; SOFTWARE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037220165     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10187     Document Type: Review

References (32)

1. Antonarakis SE. 1998. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11:1-3.
2. Bairoch A, Boeckmann B. 1991. The SWISS-PROT protein sequence data bank. Nucleic Acids Res 19(Suppl):2247-2249.
3. Beroud C, Verdier F, Soussi T. 1996. p53 gene mutation: software and database. Nucleic Acids Res 24:147-150.
4. Beroud C, Soussi T 1996. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24:121-124.
5. Beroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C. 1998. Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26:256-258.
6. Beroud C, Soussi T. 1998. p53 gene mutation: software and database. Nucleic Acids Res 26:200-204.
7. Beroud C, Collod-Beroud G, Boileau C, Soussi T, Junien C. 2000. UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat 15:86-94.
8. Bilofsky HS, Burks C, Fickett JW, Goad WB, Lewitter FI, Rindone WP, Swindell CD, Tung CS. 1986. The GenBank genetic sequence databank. Nucleic Acids Res 14:1-4.
9. Cariello NF, Beroud C, Soussi T. 1994. Database and software for the analysis of mutations at the human p53 gene. Nucleic Acids Res 22:3549-3550.
10. Collod-Beroud G, Beroud C, Ades L, Black C, Boxer M, Brock DJ, Godfrey M, Hayward C, Karttunen L, Milewicz D, Peltonen L, Richards RI, Wang M, Junien C, Boileau C. 1997. Marfan database (second edition): software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res 25:147-150.
11. Cuticchia AJ. 2000. Future vision of the GDB human genome database. Hum Mutat 15:62-67.
12. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12.
13. den Dunnen JT, Antonarakis SE. 2001. Nomenclature for the description of human sequence variations. Hum Genet 109:121-124.
14. Hamm GH, Cameron GN. 1986. The EMBL data library. Nucleic Acids Res 14:5-9.
15. Jeanpierre C, Beroud C, Niaudet P, Junien C. 1998. Software and database for the analysis of mutations in the human WT1 gene. Nucleic Acids Res 26:271-274.
16. Kucera E, Speiser P, Gnant M, Szabo L, Samonigg H, Hausmaninger H, Mittlbock M, Fridrik M, Seifert M, Kubista E, Reiner A, Zeillinger R, Jakesz R. 1999. Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian breast cancer study group. Eur J Cancer 35:398-405.
17. Lou MA, Tseng SL, Chang SF, Yue CT, Chang BL, Chou CH, Yang SL, Teh BH, Wu CW, Shen CY. 1997. Novel patterns of p53 abnormality in breast cancer from Taiwan: experience from a low-incidence area. Br J Cancer 75:746-751.
18. Mineta H, Borg A, Dictor M, Wahlberg P, Akervall J, Wennerberg J. 1998. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer 78:1084-1090.
19. Nakanishi H, Tomita Y, Myoui A, Yoshikawa H, Sakai K, Kato Y, Ochi T, Aozasa K. 1998. Mutation of the p53 gene in postradiation sarcoma. Lab Invest 78:727-733.
20. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607-614.
21. Pearson PL. 1991. The genome data base (GDB): a human gene mapping repository. Nucleic Acids Res 19(Suppl):2237-2239.
22. Ramnani DM, Wistuba II, Behrens C, Gazdar AF, Sobin LH, Albores-Saavedra J. 1999. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer 86:14-21.
23. Senapathy P, Shapiro MB, Harris NL. 1990. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol 183:252-278.
24. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. 2002. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179:175-183.
25. Soussi T, May P. 1996. Structural aspects of the p53 protein in relation to gene evolution: a second look. J Mol Biol 260:623-637.
26. Soussi T, Beroud C. 2001. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1:233-240.
27. Soussi T, Beroud C. 2003. Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides. Hum Mutat 21:192-200.
28. Suzuki T, Shidara K, Hara F, Nakajima T. 1994. High frequency of p53 abnormality in laryngeal cancers of heavy smokers and its relation to human papillomavirus infection. Jpn J Cancer Res 85:1087-1093.
29. Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, Tsai CH. 2002. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope 112:116-119.
30. Varret M, Rabes JP, Thiart R, Kotze MJ, Baron H, Cenarro A, Descamps O, Ebhardt M, Hondelijn JC, Kostner GM, Miyake Y, Pocovi M, Schmidt H, Schuster H, Stuhrmann M, Yamamura T, Junien C, Beroud C, Boileau C. 1998. LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis. Nucleic Acids Res 26:248-252.
31. Wautot V, Vercherat C, Lespinasse J, Chambe B, Lenoir GM, Zhang CX, Porchet N, Cordier M, Beroud C, Calender A. 2002. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat 20:35-47.
32. Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press ME 1999. p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol 18:29-41.